Sensus Healthcare, Inc. (SRTS)
NASDAQ: SRTS · Real-Time Price · USD
4.665
-0.065 (-1.37%)
Apr 1, 2025, 10:27 AM EDT - Market open
Sensus Healthcare Revenue
In the year 2024, Sensus Healthcare had annual revenue of $41.81M with 71.31% growth. Sensus Healthcare had revenue of $13.07M in the quarter ending December 31, 2024, with 3.97% growth.
Revenue (ttm)
$41.81M
Revenue Growth
+71.31%
P/S Ratio
1.85
Revenue / Employee
$774,204
Employees
54
Market Cap
76.95M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 41.81M | 17.40M | 71.31% |
Dec 31, 2023 | 24.41M | -20.13M | -45.20% |
Dec 31, 2022 | 44.53M | 17.49M | 64.68% |
Dec 31, 2021 | 27.04M | 17.47M | 182.36% |
Dec 31, 2020 | 9.58M | -17.69M | -64.87% |
Dec 31, 2019 | Pro | Pro | Pro |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
UnitedHealth Group | 400.28B |
Johnson & Johnson | 88.82B |
Merck & Co. | 64.17B |
AbbVie | 56.33B |
AstraZeneca | 54.07B |
Novartis AG | 51.72B |
Eli Lilly and Company | 45.04B |
Thermo Fisher Scientific | 42.88B |
SRTS News
- 19 days ago - Sensus Healthcare to Participate in the 37th Annual ROTH Conference - Business Wire
- 26 days ago - Sensus Healthcare to Showcase Commercial and Late-Stage Products at the American Academy of Dermatology Annual Meeting - Business Wire
- 4 weeks ago - Sensus Healthcare Announces Publication of Study at Tri Service Military Hospital in Taiwan Demonstrating Efficacy of SRT-100® in Preventing Keloid Recurrence - Business Wire
- 7 weeks ago - Sensus Healthcare Buys Back Shares - Business Wire
- 7 weeks ago - Sensus Healthcare: A Tough Q1 2025 Awaits Ahead - Seeking Alpha
- 7 weeks ago - Sensus Healthcare, Inc. (SRTS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 7 weeks ago - Sensus Healthcare Reports Fourth Quarter and Full Year 2024 Financial Results - Business Wire
- 2 months ago - Sensus Healthcare to Present at The Microcap Conference 2025 - Business Wire